HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE-Reference-Cited by-同舟云学术

HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE

Published:2020-06-02 Issue:2 Volume:1 Page:46-51
ISSN:2686-9039
Container-title:South Russian Journal of Cancer
language:
Short-container-title:jour

Author:

Vladimirova L. Yu.¹^ORCID,Storozhakova A. E.¹^ORCID,Snezhko T. A.¹^ORCID,Strakhova L. K.¹^ORCID,Abramova N. A.¹^ORCID,Kabanov S. N.¹^ORCID,Kalabanova E. A.¹^ORCID,Samaneva N. Yu.¹^ORCID,Svetitskaya Ya. V.¹^ORCID,Tishina A. V.¹^ORCID

Affiliation:

1. National Medical Research Centre for Oncology of the Ministry of Health of Russia

Publisher

ANO -Perspective of Oncology

Reference10 articles.

1. Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat. 2002 Nov; 76(1): 27–36. https://doi.org/10.1023/a:1020299707510

2. Beaver JA, Amiri‑Kordestani L, Charlab R, Chen W, Palmby T, Tilley A, et al. FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor‑Positive, HER2‑Negative Metastatic Breast Cancer. Clin Cancer Res. 2015 Nov 1; 21(21): 4760–4766. https://doi.org/10.1158/1078–0432.CCR‑15–1185

3. Robertson JFR, Bondarenko IM, Trishkina E, Dvorkin M, Panasci L, Manikhas A, et al. Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor‑positive advanced breast cancer (FALCON): an international, randomised, double‑blind, phase 3 trial. Lancet. 2016 Dec 17; 388(10063): 2997–3005. https://doi.org/10.1016/S0140–6736(16)32389–3

4. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, et al. ESO‑ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Ann Oncol. 2014 Oct; 25(10): 1871–1888. https://doi.org/10.1093/annonc/mdu385

5. Fan W, Chang J, Fu P. Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies. Future Med Chem. 2015 Aug; 7(12): 1511–1519. https://doi.org/10.4155/fmc.15.93

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cultivation of cells in alginate drops as a high-performance method of obtaining cell spheroids for bioprinting;South Russian Journal of Cancer;2023-05-11

2. Paget’s disease of the breast: a contemporary perspective;Research and Practical Medicine Journal;2023-04-05

3. Blood coagulation system state in breast cancer patients that recovered from coronaviral infection after undergoing antitumor medical treatment;Research and Practical Medicine Journal;2022-08-17

4. Evaluation of the results of neoadjuvant treatment in patients with HER2 positive breast cancer subtype;Kazan medical journal;2022-08-15

5. Creation of a collection of frozen tumor tissue and deemed healthy tissues of breast cancer patients;Profilakticheskaya meditsina;2022